Literature DB >> 24652775

Pharmacokinetics of honokiol after intravenous guttae in beagle dogs assessed using ultra-performance liquid chromatography-tandem mass spectrometry.

Yi Liang1, Gang Cui, Xiaoxue Wang, Wei Zhang, Quan An, Zongtao Lin, Hong Wang, Shizhong Chen.   

Abstract

A simple, rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the determination of honokiol in beagle dog plasma after intravenous guttae. With addition of the internal standard magnolol, plasma samples were precipitated with methanol and separated on a Shim-pack XR-ODS II (2.0 × 100 mm, 2.2 µm) with isocratic elution of methanol and water (80:20) solution at a flow rate of 0.2 mL/min. A good separation of honokiol was achieved within 3.5 min. Quantification was performed on a Waters Quattro Premier XE triple quadrupole mass spectrometer with electrospray ionization inlet in the negative multiple reaction monitoring mode. Good linearity was obtained over the concentration range of 5.12-15580 ng/mL (r(2) > 0.998). Intra- and inter-day precisions were <13.10%, and accuracy ranged from 89.21 to 99.92%. The lower limit of quantification for honokiol was 5.12 ng/mL, and honokiol was stable under various conditions (three freeze-thaw cycles, short-term temperature, post-preparative and long-term temperature conditions.). This validated method was successfully applied to the pharmacokinetic study of honokiol in dogs by intravenous guttae.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  UPLC-MS/MS; beagle dog; honokiol; pharmacokinetics; plasma

Mesh:

Substances:

Year:  2014        PMID: 24652775     DOI: 10.1002/bmc.3179

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Authors:  Xu Wang; Jonathan J Beitler; Wen Huang; Guo Chen; Guoqing Qian; Kelly Magliocca; Mihir R Patel; Amy Y Chen; Jun Zhang; Sreenivas Nannapaneni; Sungjin Kim; Zhengjia Chen; Xingming Deng; Nabil F Saba; Zhuo Georgia Chen; Jack L Arbiser; Dong M Shin
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531

2.  The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats.

Authors:  Wang Jun-Jun; Miao Xiao-Lei; Chen Jing-Ya; Chen Yong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

3.  Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.

Authors:  Daniel Herrmann; Andrea Schreiber; Anna Ciotkowska; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Christian Gratzke; Martin Hennenberg
Journal:  Prostate Int       Date:  2014-08-26

Review 4.  Honokiol: A Review of Its Anticancer Potential and Mechanisms.

Authors:  Chon Phin Ong; Wai Leong Lee; Yin Quan Tang; Wei Hsum Yap
Journal:  Cancers (Basel)       Date:  2019-12-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.